BioSpace News Archive

CENTOGENE expands its SARS-CoV-2 testing solution to Berlin Brandenburg Airport (BER) after successfully launching COVID-19 test centers at three major German airports in cooperation with Lufthansa

PureTech Health plc announced that Daphne Zohar, founder and chief executive officer, will present at the 29th Annual Credit Suisse Virtual Healthcare Conference on Thursday, November 12, at 2:00 PM EST.

Alligator Bioscience announced that its CD40 targeting antibody mitazalimab will be presented at the World Immunotherapy Congress, November 2-6, 2020.

XPhyto Therapeutics Corp., a next-generation bioscience accelerator, is pleased to announce the appointment of Mr. Per S. Thoresen to the Company’s board of directors effective immediately.

Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, announced financial results for its fiscal 2021 second quarter that ended September 30, 2020.

RadNet, Inc. announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Jefferies Virtual London Healthcare Conference on Thursday, November 19, 2020 at 10:10 a.m. Pacific Time.

Our focus this year has been to advance our proprietary pipeline. Our team has diligently and effectively executed on our plan, and I’m pleased that we have achieved our stated 2020 pipeline milestones.

− Initiation of Phase 3 Objective Sign Trial in Dry Eye Disease Planned for the Fourth Quarter 2020 − Phase 2 Clinical Trials of ADX-629 in COVID-19, Atopic Asthma, and Psoriasis Expected to Initiate in the Fourth Quarter of 2020 − Top-line Results from the Phase 3 INVIGORATE Clinical Trial in Allergic Conjunctivitis Expected in the First Half of 2021 − Cash, Cash Equivalents, and Marketable Securities of $86.2 Million as of September 30

Partnership to support Taysha’s broad gene therapy pipeline Development and manufacturing partnership will support future preclinical and clinical supply for several gene therapy programs, including CLN1 and Rett syndrome

Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, together with the existing Envision management team and employees, have increased their investment in Envision Pharma Group (“Envision” or the “Company”), a leading technology-enabled scientific communications compa